The global pulmonary drug delivery systems market size is expected to reach USD 55.1 billion by 2025, according to a new report by Grand View Research, Inc., Increasing prevalence of chronic respiratory diseases is expected to boost the adoption of Pulmonary Drug Delivery Systems (PDDS). As per WHO, 235 million people suffer from asthma globally. Majority of the asthma-related deaths occur in middle- to low-income countries due to a lack of treatment options. This shows the potential demand for pulmonary drug delivery systems in the coming years.
Technological
advancements in the field of drug delivery are expected to positively impact
the pulmonary drug delivery devices market. These advancements include the
incorporation of agglomerated vesicle technology, MDI electronic dose counter,
particle engineering, and supercritical fluid technology. Rising demand for new
products, changing lifestyle, ease of use, and better facilities are factors
expected to provide lucrative opportunities.
Furthermore,
a rise in the number of public and private organizations is another major
factor propelling the growth of the pulmonary drug delivery devices market. For
instance, organizations such as the Asia Pacific Association of Allergy, Asthma
and Clinical Immunology (APAAACI) are engaged in providing information in
clinical and basic research on allergy, asthma, and clinical immunology. Such
initiatives are in turn expected to increase the market demand for respiratory
drug delivery devices in developing regions, thereby boosting the overall
market growth.
Full Research Report On Pulmonary Drug Delivery Systems Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/pulmonary-drug-delivery-systems-market
Further Key
Findings From the Study Suggest:
- Metered dose inhaler segment
held the dominant share owing to its low cost and high adoption rate due
to early introduction in the market
- Chronic Obstructive
Pulmonary Diseases (COPD) segment is anticipated to grow at a lucrative
CAGR due to the presence of favorable reimbursement policies for the
treatment of COPD
- High number of patients
affected by asthma in developing and developed regions is likely to
support the development of asthma applications for respiratory drug
delivery devices
- The E-commerce segment is
expected to witness lucrative growth. Development of this segment is
supported by its associated benefits such as convenience, discounts, and
flexibility
- Home care segment is
expected to exhibit exponential growth due to the introduction of
technologically advanced, portable, and small-sized devices that can be
used at home
- Asia Pacific region is
anticipated to grow at a lucrative CAGR. High prevalence of COPD,
indicating a substantial socioeconomic burden in this region drives the
growth in Asia Pacific
- The pulmonary drug delivery
systems market is progressing due to the rising demand for better
treatment options, efficient drug delivery, and rapid treatment of local
respiratory disorders
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/pulmonary-drug-delivery-systems-market/request/rs1
Grand View Research has segmented
the global pulmonary drug delivery systems market on the basis of product,
application, distribution channel, end use, and region:
Pulmonary Drug
Delivery Systems Product Outlook (Revenue, USD Million, 2014 - 2025)
- Metered Dose Inhalers (MDIs)
- Dry Powder Inhalers (DPIs)
- Nebulizers
- Mesh
- Vibrating
- Static
- Pneumatic
- Vented
- Breath Actuated
- Ultrasonic
- Accessories
Pulmonary Drug
Delivery Systems Application Outlook (Revenue, USD Million, 2014 - 2025)
- Asthma
- Cystic Fibrosis
- COPD
- Allergic Rhinitis
- Others
Pulmonary Drug
Delivery Systems Distribution Channel Outlook (Revenue, USD Million, 2014
- 2025)
- Retail Pharmacies
- Hospital Pharmacies
- E-Commerce
Pulmonary Drug
Delivery Systems End-Use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals & Clinic
- Homecare
Pulmonary Drug
Delivery Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment